What We Do

About Ida


In the Press

August 8, 2019

Adding MS Drug to Targeted Cancer Therapy May Improve Glioblastoma Outcomes

By reaching stem cells at the tumor’s root, multiple sclerosis drug teriflunomide, paired with targeted cancer therapy, markedly shrinks patient-derived glioblastomas grown in mice, with senior author of this study is Dr. Jeremy Rich.

June 25, 2019

California Protons Is Now Affiliated With UC San Diego Health Cancer Network

As of May 2019, California Protons Cancer Therapy Center is now affiliated with UC San Diego Health Cancer Network, giving more patients access to world-class, lifesaving proton therapy treatment provided by radiation oncologists from Moores Cancer Center at UC San Diego Health, San Diego’s only National Cancer Institute-Designated Comprehensive Cancer Center.

June 25, 2019

As state funding runs out, California stem cell scientists get $30 million gift

California stem cell researchers are getting $30 million to advance therapies for diseases of youth to old age under three grants from the Eli and Edythe Broad Foundation. They come when California’s $3 billion stem cell program, which has funded work from San Diego to Sacramento, is winding down.

June 23, 2019

How ‘Human on a Chip’ Technology Could Change the Way We Test Drugs

The new technology could eliminate the need for animal testing in many instances and has some profound implications for new cancer treatments, with Dr. Razelle Kurzrock weighing in.

June 18, 2019

Treatments on the Horizon for Cancers Linked to Epstein-Barr Virus

Initial results from clinical trials show new drug therapies are effective against lymphomas and other cancers connected to the Epstein-Barr virus, with lymphoma expert Dr. Erin Reid weighing in.

June 16, 2019

ONCTERNAL RETAINS CEO, WILL REMAIN IN SAN DIEGO: Reverse Merger To Support Co.’s Cancer Candidates

On the heels of auspicious clinical trial results, San Diego-based Oncternal Therapeutics completed a reverse merger with Tennessee’s GTx, it was announced June 10. Dr. Michael Choi, investigator in their CLL clinical trial gives insights into the combination study.

June 6, 2019

UCTV Launches New Stem Cell Channel

The new channel talked to Dr. Catriona Jamieson about how that information forms the basis for new leukemia therapies that she’s testing in clinical trials in our Alpha Stem Cell Clinic.

May 29, 2019

Dr. Cohen on the Era Before Immunotherapy in Head and Neck Cancer

Dr. Ezra Cohen discusses the treatment era before immunotherapy in head and neck cancer.

May 22, 2019

New study finds diet may reduce risk of breast cancer death

A new study shows that sticking to a low-fat, plant-based diet could reduce a woman’s risk of dying from breast cancer. Joining KUSI to discuss this study further is Dr. Anne Wallace.

May 22, 2019

The Top 25 Voices in Precision Medicine announced by BIS Research

Success in precision medicine has been largely dependent on thought leaders who are highly skilled interdisciplinary leaders, including Dr. Razelle Kurzrock.

May 21, 2019

Ignite San Diego: Local Business Spotlight of UC San Diego Moores Cancer Center

The industry relations department at UC San Diego Health’s Moores Cancer Center is tasked with translating UC San Diego faculty’s work into therapies, medical devices and other medical treatment, led by Dr. Ida Deichaite.

May 20, 2019

HEALTH: ARM OF MOORES CANCER CENTER HOLDS ANNUAL SYMPOSIUM: Office Bridges Gap Between Discovery, Therapeutics

UC San Diego Health’s Moores Cancer Center has an arm that’s charged with translating UC San Diego work into breakthrough therapies - led by Dr. Ida Deichaite. Reporter Jared Whitlock interviews Deichaite to learn about the symposium and groundbreaking oncology discoveries facilitated by our office.

May 15, 2019

Frontline Cancer: Knowledge is power; Leveraging genetic cancer predispositions

Cancer Center Director Dr. Scott Lippman explains our ability to discover inherited genetic differences that increase cancer risk, including site and type of cancer, has grown exponentially over the past few years, along with our understanding of the familial and genetic basis of cancer.

May 13, 2019

FDA will not ban textured implants that are linked to cancer

Dr. Anne Wallace, director of UC San Diego Health’s Comprehensive Breast Health Center joined Good Morning San Diego to discuss the Food and Drug Administration decision to decline to ban the sale of textured breast implants.

April 24, 2019

Exposing Cancer’s Metabolic Addictions

The article features research from senior authorDr. Paul Mischel: Real estate is important: where a tumor arises dictates specific metabolic vulnerabilities, identifying potential targets for effective cancer treatments.

April 22, 2019

Woman’s lethal cancer disappears after gene-matched therapy, leaving her in full remission

Near death, Teresa McKeown went into complete remission with lethal breast cancer, under the I-PREDICT trial, guided by her doctor and surgeon Dr. Jason Sicklick.

April 22, 2019

Personalizing Precision Medicine with Combination Therapies Improves Outcomes in Cancer

In a report, published online in Nature Medicine on April 22, 2019, senior authors Drs. Jason Sicklick and Razelle Kurzrock in partnership with lead investigator Dr. Shumei Kato, found that treating patients with personalized, combination therapies improved outcomes in patients with therapy resistant cancers.

April 22, 2019

Comprehensive Tumor Profiling Promises New Therapeutic Options for Patients with Advanced Cancer

Published in Nature Medicine today, results of WINTHER, the first study pioneered by the WIN Consortium, including investigator Dr. Razelle Kurzrock, shows that RNA profiling together with DNA testing matches more patients with advanced cancer to personalized therapies than DNA profiling for tumor mutations alone.

April 18, 2019

Nigeria nears clinical trials for stem cell therapies

The article features research from Dr. Dan Kaufman: after extensive preclinical testing, the US Food and Drug Administration (FDA) gave Dr. Kaufman and Fate Therapeutics the go-ahead last November to set up a phase I clinical trial to test their iPS-derived NK immunotherapy in people with advanced solid tumours.

April 12, 2019

Nigeria nears clinical trials for stem cell therapies

Fate Therapeutics begins experimental testing of ‘natural killer’ cells in cancer, working closely with expert Dr. Dan Kaufman. The first patient, Derek Ruff, was treated by Dr. Sandip Patel for his recurrent stage four colon cancer.

March 7, 2019

How the Microbiome Could Be the Key to New Cancer Treatments

The effectiveness of drugs that help the immune system fight cancer cells appears to depend on bacteria in the gut, featuring research from Dr. Rob Knight.

March 4, 2019

Poison Drummer Rikki Rockett, an HPV-Attributed Throat Cancer Survivor, Urges Public to Open Up and Say Ahhh! and GET SCREENED During the 21st Annual Oral, Head and Neck Cancer Awareness Week®

Ezra Cohen, MD, is Rockett's physician and Board Member of the Head and Neck Cancer Alliance (HNCA).

March 4, 2019

Vaccine could halt the spread of metastatic cancer

Ezra Cohen, MD and researchers at the UC San Diego Health and the La Jolla Institute for Allergy and Immunology are working on a cancer vaccine that’s specific for each patient. It’s a clinical trial that is only for people with metastatic cancer.

March 1, 2019

UC San Diego researcher gets $4 million NCI Award to study cancer drug resistance

The National Cancer Institute (NCI) has awarded David Cheresh, PhD, Distinguished Professor and vice chair of Pathology at University of California San Diego School of Medicine, with a $4.2 million Outstanding Investigator Award to continue his research into cancer’s ability to overcome stress, gain drug resistance and metastasize.

February 8, 2019

Firefighters and the Cancer Beast

Firefighters and others depend on scientists for innovations in prevention and treatment, and have mentioned our annual Industry/Academia Translational Oncology Symposium as an example of fosering new partnerships to speed new therapies to patients.

January 24, 2019

John Mendelsohn, shaper of UC San Diego's renowned cancer program, dies at 82

This profile features Drs. Scott Lippman and Razelle Kurzrock, leaders of the Cancer Center.

January 5, 2019

Healthy Living: Cancer deaths drop in U.S.

According to a study by the American Cancer Society, deaths from cancer have dropped steadily for 25 straight years, and Dr. James Murphy gives his expert opinion.

January 5, 2019

Stopping cancer from recruiting immune system double agents

Researchers, led by senior author Judy Varner, PhD, find a novel intervention that keeps tumors from enlisting myeloid cells to help them grow and spread.

January 3, 2019

An Errant Editing Enzyme Promotes Tumor Suppressor Loss and Leukemia Propagation

A research team led by senior author Dr. Catriona Jamieson found that the normal functions of the ADAR1 enzyme are hijacked by pre-malignant cells, leading to a cascade of molecular consequences that promote malignant transformation, dormant cancer stem cell generation and resistance to treatment.

January 2, 2019

Frontline Cancer: The season for family, health, hope and new beginnings

The Moores Cancer Center at UC San Diego Health is one of just a small group of centers worldwide that treat a high volume of GIST cases each year.

January 2, 2019

For biomedical industry, partial government shutdown a New Year's headache

UC San Diego researcher/oncologist Dr. Catriona Jamieson said that while work is currently moving ahead, a prolonged shutdown will increasingly interfere with research.

January 1, 2019

How personalized medicine is transforming your healthcare

This month's issue of National Geographic magazine features the story of Teresa McKeown, a patient advocate who will be speaking at our upcoming "Next Generation Precision Oncology" Symposium next month.

December 22, 2018

n=30 Next Step in Cancer Therapy: Personalized Vaccine?

The podcast features Tamara Strauss, the first patient to enroll in a first-of-its-kind clinical trial at Moores Cancer Center at UC San Diego Health to test a personalized vaccine using her unique cancer mutations to boost an anti-tumor immune response.

December 19, 2018

Preventing Pancreatic Cancer: A Q&A with Surgical Oncologist Andrew Lowy, MD

Led by Dr. Andrew Lowy, along with a multidisciplinary team with expertise in genetics, imaging, endoscopic procedures, surgery and nutrition, UC San Diego Health is creating a first-of-its-kind clinic to develop personalized prevention and early detection plans for high-risk patients seeking care at San Diego’s only NCI-designated Comprehensive Cancer Center.

December 13, 2018

Cash running short, California's stem cell agency defends its results

The California Institute for Regenerative Medicine, or CIRM, is drawing down the last of $3 billion in state bond money granted by voters in 2004 with Proposition 71. Article features MCC oncologist/researcher and CIRM grantee Dr. Catriona Jamieson.

December 12, 2018

UC San Diego to Partner with New Allen Institute for Immunology

In its initial phase, the Allen Institute for Immunology will focus on studies of two cancers (multiple myeloma and melanoma) and three autoimmune disorders — rheumatoid arthritis and inflammatory bowel disease, specifically ulcerative colitis and Crohn’s disease.

December 7, 2018

UC San Diego Researcher Gets $4 Million NCI Award to Study Cancer Drug Resistance, Spread

NCI has awarded David Cheresh, PhD, Distinguished Professor and vice chair of Pathology at University of California San Diego School of Medicine, with a $4.2 million Outstanding Investigator Award to continue his research into cancer’s ability to overcome stress, gain drug resistance and metastasize.

December 6, 2018

O.C. nonprofit empowers those with rare diseases

A patient, Merak Mlikian Hatounian, connected with UC San Diego’s a href="http://profiles.ucsd.edu/jason.sicklick">Dr. Jason Sicklick, one of the few doctors in the world studying GIST.

December 4, 2018

New Cancer Immunotherapy Approach Turns Immune Cells into Tiny Anti-Tumor Drug Factories

In lab and mouse experiments, UC San Diego School of Medicine researchers developed a method to leverage B cells to manufacture and secrete tumor-suppressing microRNAs, with senior author Maurizio Zanetti.

December 4, 2018

Study: Immunotherapy Better than Chemotherapy for Subtype of Head and Neck Cancer

Randomized clinical trial shows pembrolizumab is more effective, safer than standard therapy for disease that progresses or recurs, said Ezra Cohen, MD, professor of medicine at University of California San Diego School of Medicine and corresponding author on the study.

December 3, 2018

UC San Diego Health is First in San Diego to offer CAR T-cell Therapy for Some Cancers

Following the Food and Drug Administration’s approval of chimeric antigen receptor (CAR) T-cell therapies for the treatment of certain types of non-Hodgkin lymphomas, UC San Diego Health was the first medical center in San Diego to be certified to offer this type of immunotherapy outside of a clinical trial.

November 29, 2018

Prevention and Screening Clinic at UC San Diego Health Helping to Reduce Pancreatic Cancer

Led by Dr. Andrew Lowy, a multidisciplinary team, with expertise in genetics, imaging, endoscopic procedures, surgery and nutrition, is creating one of the first-of-its-kind clinics to develop a personalized prevention and early detection plan for each high-risk patient seeking care at San Diego’s only National Cancer Institute-designated Comprehensive Cancer Center.

November 21, 2018

Coping With Head and Neck Cancer

Dr. Ezra Cohen weighs in on the discussion about patients with head and neck cancer facing physical, social and emotional issues that can add to existing mental health problems or give rise to new ones.

November 21, 2018

Frontline Cancer: 'Vaping' not necessarily healthier than smoking

Dr. Scott Lippman, Director of the Moores Cancer Center, chimes in on the national debate.

November 20, 2018

Stand Up To Cancer Grant Funds UC San Diego Health Research in Pancreatic Cancer

Lead investigators Tannishtha Reya, PhD and Dr. Andrew Lowy have been awarded a $1 million Stand Up To Cancer (SU2C) grant to test drugs that block signals that play a critical role in driving growth and progression of pancreatic cancer.

November 19, 2018

Trial to assess ibrutinib-cirmtuzumab combination for B-cell malignancies

Dr. Tom Kipps and colleagues will conduct the phase 1b/phase 2 trial to investigate whether the addition of the monoclonal antibody cirmtuzumab to standard therapy with ibrutinib benefits patients with B-cell malignancies.

November 5, 2018

The Role of HPV Virus in Head & Neck Cancer

A study with collaborator in the laboratory of Dr. Trey Ideker identified several new protein interactions that were previously not known to cause cancer, expanding knowledge of the oncogenic roles of the HPV virus.

November 2, 2018

Tiny DNA modification has big impact on deadly tumors

A simple modification of a DNA base in small areas of the genome may explain why glioblastoma tumors are so deadly, researchers at Yale and the UCSD report Nov. 1 in the journal Cell, with senior author Dr. Jeremy Rich.

October 28, 2018

California’s low lung cancer rates saves nearly 5,000 lives

California’s low rate of lung cancer deaths saved nearly 5,000 lives in 2014 — and saved Californians at least $500 million just in that year, according to a CALmatters analysis in consultation with public health researchers, including John Pierce, PhD.

October 11, 2018

Hormone Therapy for Prostate Cancer Not Significantly Linked to Subsequent Dementia

A team of epidemiologists and doctors at UC San Diego School of Medicine and Veterans Affairs San Diego Health Care System investigated the association between ADT and dementia in over 45,000 veterans who were diagnosed with prostate cancer between 2001 and 2015.

October 5, 2018

"When Cancer Genomics Research Outpaces the Regulation of Genomics Data: Does the Patient Win Or Lose?"

We congratulate our summer student Alice Lu, for the incredible accomplishment of receiving 1st Prize – Best Poster Presentation at the 2018 International Cancer Education Conference (https://2018.attendicec.org/), held October 3 – 5, 2018 in Atlanta, Georgia. Authors: Alice Lu, BS, BA, Georgia Robins Sadler, BSN, MBA, PhD, and Ida Deichaite, PhD, UC San Diego Moores Cancer Center.

October 4, 2018

Dr. Cohen on Immunotherapeutic Advances in Head and Neck Cancer

Dr. Ezra Cohen discusses immunotherapeutic advances in head and neck cancer, including investigational combinations showing impressive efficacy.

September 30, 2018

Conquering cancer by attacking the disease’s genetic abnormalities

Comprehensive tumor profiling — in which individuals are matched with drugs that target specific genetic mutations or other abnormalities — is becoming a cornerstone of cancer treatment. This features Dr. Razelle Kurzrock.

September 30, 2018

An Oncologist on Why the Patient Partnership is Sacred

Dr. Barbara Parker, the medical director at UC San Diego Health's Moores Cancer Center, reveals why the dynamic is an important "obligation".

September 26, 2018

AI and Machine Learning for Clinical Trials – Examining 3 Current Applications

AI helped the Moores Cancer Center at UC San Diego Health shorten its study timelines by nearly 33% and reduce data errors by 20%.

September 24, 2018

What Not To Say To Someone With Cancer

When someone has cancer and they’re told they need to “stay positive,” it becomes another stressor for them, explains psychiatrist Dr. Alan Hsu.

September 20, 2018

Cancer Immunotherapy Might Benefit From Previously Overlooked Immune Players

Genetic data for nearly 6,000 patients and their tumors highlight the previously underappreciated role CD4+ T cells and MHC-II molecules play in keeping cancer at bay, from research led by Hannah Carter, PhD.

September 13, 2018

Engineered natural killer cells may be the next great cancer immunotherapy

Earlier this year, for instance, stem cell biologist Dr. Dan Kaufman and colleagues reported that in mice, CAR NK cells perform about as well against ovarian tumors as CAR T cells do—and substantially better than unaltered NK cells.

August 30, 2018

Frontline Cancer: Doctors debate best age to screen for colon cancer

Dr. Scott Lippman discusses Dr. Samir Gupta's recent paper in Gastroenterology that explores potential consequences of recommending persons be screened for colorectal cancer first at age 45 instead of age 50.

August 27, 2018

Researchers to Test Novel Drug Combination Against Toughest Breast Cancers

The Phase I clinical trial will combine standard chemotherapy with cirmtuzumab, a drug that has shown promise against a variety of cancer types. The drug was originally developed by Dr. Tom Kipps, with Co-PIs Drs. Barbara Parker and Rebecca Shatsky, and will be in the Alpha Clinic run by Dr. Catriona Jamieson.

August 26, 2018

Why did Carter and McCain have such different brain tumor results?

Dr. Ezra Cohen weighs in on deadly brain tumors that have challenged political icons President Jimmy Carter and Senator John McCain.

August 22, 2018

Why Dr. Samir Gupta is calling for caution over the American Cancer Society's new screening guideline

The American Cancer Society lowered the recommended age to begin screening for colorectal cancer from 50 to 45, but Dr. Samir Gupta said the updated guideline should be implemented cautiously.

August 21, 2018

Natural killer cells as effective as, less toxic than T cells

Natural killer cells engineered with chimeric antigen receptors demonstrated comparable efficacy as T cells but appeared less toxic, according to study results and Dr. Dan Kaufman.

August 21, 2018

Cover Your Butt: When to Screen for Colorectal Cancer

A diverse team of national experts, led by Dr. Samir Gupta, published a commentary in Gastroenterology calling for cation in the widesoread implementation of recommendations for early screening of colorectal cancer for the entire population.

August 19, 2018

Surfing legends, researchers and survivors ride La Jolla waves to fight cancer

Dozens of accomplished surfers teamed up with medical experts and cancer survivors to compete in the 25th Annual Luar and Legends of Surfing Invitational, including Dr. Andrew Sharabi.

August 10, 2018

Meeting the Challenges of Immunotherapy-Related Toxicities

The ASCO Post discusses overcoming the treatment challenges of immunotherapy in the palliative care setting, assessing the risk factors for immunotherapy side effects, and managing patients’ unrealistic expectations, featuring expert commentary from Dr. Sandip Patel.

August 8, 2018

Genetic Mutations of Appendix Cancer Identified, May Impact Treatment

Appendix cancer is currently treated like colon cancer, but significant differences may alter therapy choices, says senior author Olivier Harismendy giving expert commentary.

July 30, 2018

Pregnant with Cancer: Second Opinion Critical

Dr. Parag Sanghvi at UC San Diego and colleagues came up with a plan that let a pregnant woman with tonsil cancer keep her baby.

July 30, 2018

Drinking while breastfeeding tied to cognitive problems in young kids

Breastfeeding mothers who drink alcohol may be more likely to have children with cognitive problems than women who abstain while nursing, an Australian study suggests, with Christina Chambers, PhD, MPH giving expert commentary.

July 26, 2018

Panel on BRCA genes in La Jolla explains cancer risks

Moderated by author and journalist Jill Werman Harris, the panel included Basser Center for BRCA executive director Susan Domchek, Abelsohn, Scripps Hospital Surgical Associates founder Paul Hyde, La Jolla IVF founder and medical director David Smotrich, and UC San Diego’s Moores Cancer Center family center genetics program director Lisa Madlensky.

July 18, 2018

Frontline Cancer: Some cancers may be suitable targets of iPSC-derived NK cells

In a recent paper, published in Cell Stem Cell, Dr. Dan Kaufman and colleagues reported that modified NK cells derived from human-induced pluripotent stem cells (iPSCs, the cells that can become almost any type of cell) also displayed heightened activity against a mouse model of ovarian cancer.

July 18, 2018

Cancer victim gets new tongue made from her leg

'I was so hungry I wanted to bury my face in KFC': Cancer victim gets new tongue made from her leg - and the first thing she could taste was super salty fried chicken, featuring her surgeon Dr. Joseph Califano, UC San Diego Moores Cancer Center genetics program director.

July 18, 2018

Early dinner time associated with lower risk of cancer, says study

A new study suggests people who eat dinner early or wait at least two hours before going to sleep have a lower risk for cancer. The research is not new - in 2015, a study published in PLoS One from UCSD found eating more frequently and less often at night could lower the risk of breast cancer.

July 10, 2018

Free panel to explore living with inherited cancer risk

According to UC San Diego researchers, curcumin binds to the DYRK2 at the atomic level, and this previously unreported biochemical interaction of curcuminnyone who has cancer in their family tree can benefit from a free expert panel discussion on July 17, featuring Dr. Lisa Madlensky, UC San Diego Moores Cancer Center genetics program director.

July 9, 2018

Crystal Structure Reveals How Curcumin Impairs Cancer

According to UC San Diego researchers, curcumin binds to the DYRK2 at the atomic level, and this previously unreported biochemical interaction of curcumin leads to inhibition of DYRK2 that impairs cell proliferation and reduces cancer burden.

July 6, 2018

Why Vitamin D May Reduce Risk for Breast Cancer

In a new study, researchers get down to the molecular level to determine why vitamin D appears to decrease a woman’s chance of developing breast cancer.

June 28, 2018

CAR-T Immunotherapies May Have a New Player

Study with senior author Dan Kaufman, MD, PhD finds that natural killer cells engineered with chimeric antigen receptors are equally effective and bring different advantages with less toxicity.

June 27, 2018

SDSU Alum Tammy Blackburn Reaches Milestone in Cancer Battle

Blackburn had her family, friends and treatment team gather for the celebration at UC San Diego's Moores Cancer Center, marking the end of her eight months of treatment for stage 2 ductal carcinoma breast cancer.

June 25, 2018

Clinical trial inclusion, specialist collaboration can improve cancer outcomes for those with HIV

Dr. Erin Reid comments on AIDS- versus non-AIDS-defining cancer incidence and aging.

June 24, 2018

SBP and UCSD Researchers Awarded 2018 Padres Pedal The Cause Grants

Sanford Burnham Prebys Medical Discovery Institute is pleased to announce that it has been awarded four Padres Pedal the Cause (PPTC) collaborative grants with UC San Diego Moores Cancer Center.

June 14, 2018

Healthcast: Pregnant with cancer

Dr. Parag Sanghvi and colleagues came up with a plan that let a pregnant cancer patient tonsil cancer keep her baby.

June 8, 2018

Chemo bath: Wiping out cancer where recurrence used to be a probability

Dr. Andy Lowy says that HIPEC is increasing cure rates of several cancer of abdominal organs, and has been successful for patients with cancers of the appendix, colon, ovaries, stomach and mesothelioma.

June 5, 2018

Building the Alpha Stem Cell CLinic Network

Dr. Catriona Jamieson and Mary Donohoe describe in detail how the resulting network of Alpha Stem Cell Clinics has significantly advanced the idea of stem cells and regenerative medicine from much-touted promise to practice.

June 3, 2018

Healthy Living: New study shows most women with early breast cancer don’t need chemo

A major new study shows many breast cancer patients in the early stages of the disease can safely skip chemotherapy, with input from Dr. Richard Schwab.

June 3, 2018

A Love of Science Leads to an Esteemed Career in Cancer Research for Razelle Kurzrock, MD

The ASCO Post Narratives Special Issues features a spotlight on Dr. Razelle Kurzrock.

May 31, 2018

Stem cell banking an unclear path for regenerative medicine: 4 notes

Dr. Dan Kaufman gave his input on stem cell banking research.

May 30, 2018

Frontline Cancer: Are you in for All of Us Research Program?

Cancer scientists and doctors have been pushing and practicing personalized medicine for several years, the idea behind the All of Us Research Program, and nowhere more so than at Moores Cancer Center at UC San Diego Health, says MCC Director Dr. Scott Lippman.

May 24, 2018

Frontline Ibrutinib Plus Obinutuzumab Improves PFS in Phase III CLL Trial

Dr. Michael Choi commented on the initial Icll-07 Filo study data in an Insights segment on OncLive.

May 17, 2018

New Blood Test Rapidly Detects Signs of Pancreatic Cancer

A new diagnostic test developed by researchers at UC San Diego shows promise for detecting pancreatic disease earlier.

May 10, 2018

We Need You: Join All of Us to Advance Precision Medicine

UC San Diego Health researchers call for volunteers to participate in landmark precision medicine research effort, including Dr. Razelle Kurzrock.

May 7, 2018

Non-Aspirin NSAIDs Offer No Survival Advantage in Metastatic RCC

This is the first such study in this group,with findings running counter to prior research in other cancers, with senior author of the study Dr. Rana McKay.

April 25, 2018

Breathe easier with lung cancer screenings

UC San Diego Health established a new lung cancer screening program to help current and former smokers determine their risk for lung cancer. The program is led by Dr. Mark Onaitis.

April 20, 2018

Keytruda Performs Well in Latest Lung Cancer Clinical Trials

The immunotherapy drug has been successful in treating other cancers and the latest trials provide hope for people battling lung cancer. The piece features Dr. Sandip Patel.

April 12, 2018

What You Need to Know About Head and Neck Cancer

Cancer.Net has a new blog about Head and Neck Cancer written by Dr. Kathryn Gold.

April 9, 2018

Cutting-edge cancer drug hobbled by diagnostic test confusion

Physicians struggle to identify which patients are likely to respond to a recently approved therapy, with input from Dr. Razelle Kurzrock.

April 5, 2018

Bryce Olson Wants To Raise Awareness About Precision Medicine. His Rallying Cry: 'Sequence Me'

Bryce Olson's story and collaboration with UC San Diego Moores Cancer Center is told in Forbes, featuring his collaboration team that includes Ida Deichaite, PhD, Director of Industry Relations, Pablo Tamayo, PhD, and Christina Jamieson, PhD.

April 2, 2018

Surprise! Medical Research a Big Winner in New Federal Budget

Despite the president’s threats to cut funding, Congress approved budget increases for cancer, Alzheimer’s, and other medical research. The article features research by Dr. Ezra Cohen.

April 2, 2018

Even DNA that Doesn’t Encode Genes Can Drive Cancer

A trove of previously overlooked genetic mutations play a role in cancer, providing nearly 200 new opportunities for molecularly targeted therapeutics, in a study by senior author Trey Ideker, PhD.

March 28, 2018

Local Realtors and restaurants team up for fundraiser

Local real estate agents and Conejo Valley restaurants are participating in an April effort to raise funds for research into a rare cancer of the gastrointestinal tract, one that has afflicted a 2017 Westlake High School graduate over the past year, and will support research being done by Dr. Jason Sicklick.

March 25, 2018

Expert Point of View: Ezra Cohen, MD, PhD

Discussant for the abstract, Dr. Ezra Cohen pointed out that although this subgroup may be responsive to checkpoint inhibition, it may not necessarily be anti–programmed cell death protein 1 (anti–PD-1) therapy.

March 20, 2018

Dr. Sacco on Ongoing Trials for Chemoradiation in Head and Neck Cancer

Assuntina G. Sacco, MD, assistant professor of medicine, medical oncologist, UC San Diego Health, discusses ongoing trials investigating chemoradiation for patients with head and neck cancer.

March 16, 2018

Comprehensive Breast Health Center Expands at UC San Diego Health

The Comprehensive Breast Health Center is located within the Koman Family Outpatient Pavilion at UC San Diego Health, and the facility offers women and men new options for breast cancer care.

March 9, 2018

Tissue-agnostic cancer drug pipeline grows, despite doubts

The FDA could soon approve the first drug developed explicitly for a tissue-agnostic cancer indication, but biological complexity may limit this approach. This Nature Review Drug Discovery article features Dr. Razelle Kurzrock.

March 9, 2018

UC San Diego Researchers Launch Combination Drug Trial to Eradicate B-Cell Malignancies

It’s hoped the two new drugs in tandem can fully clear leukemias and other blood cancers. This trial consists of PI Dr. Catriona Jamieson, was developed by Dr. Tom Kipps, and team member Dr. Michael Choi.

March 2, 2018

Watering Dandelions with Chemo Bath

UC San Diego Health milestone: 500 patients undergo HIPEC while ovarian cancer meets new foe, featuring HIPEC team members Drs. Andy Lowy, Jula Veerapong, Joel Baumgartner, and Kaitlyn Kelly.

March 1, 2018

Stand Up To Cancer dream team strives for ‘active interception’ of pancreatic cancer

The Stand Up To Cancer foundation has formed a “dream team” to identify new ways to detect pancreatic cancer at earlier stages when it is most amenable to treatment, which includes UC San Diego Moores Cancer Center.

March 1, 2018

Former SDSU Basketball Star Opens Up About Cancer Battle

Tammy Blackburn leads a jam-packed life with no desire to slow down for the "Big C." Her treatment is at UC San Diego Moores Cancer Center.

February 28, 2018

Not Enough People With HIV Receive Proper Cancer Treatment

Recognizing this threat to the health and longevity of the HIV population, the National Comprehensive Cancer Network (NCCN) has issued new guidelines on treating cancer among them, with Panel Co-Chair Dr. Erin Reid.

February 23, 2018

Cancer therapy poised for rapid advances, noted researcher says

Duane Roth Endowed Award Lecture recipient Dr, Carl June, a pioneer in CAR T cell therapy, presented information from research yet to be published pointing to advances in immunotherapy on Thursday February 22, 2018 at the Translational Oncology symposium.

February 23, 2018

Scripps Research CEO outlines path to financial sustainability

Translational Oncology Symposium Keynote Speaker Dr. Peter Schultz outlined progress towards financial independence within three to five years at the event on Thursday February 22, 2018.

January 31, 2018

Frontline Cancer: Precision medicine having an impact on clinical trials

Clinical trials are the final step before a new drug or treatment is approved for broad use in patients, with many at UC San Diego Moores Cancer Center.

January 8, 2018

Celgene to buy San Diego cancer-drug maker Impact for $1.1B

Celgene Corp. agreed to buy closely held San Diego-based Impact Biomedicines for $1.1 billion upfront to gain an experimental blood cancer treatment, with founder Dr. Catriona Jamieson.

January 4, 2018

Physical activity may improve cognitive function among breast cancer survivors

Increased physical activity improved cognitive function among a cohort of breast cancer survivors who were 2 years beyond surgery, according to study results by senior author Sheri Hartman,.

December 20, 2017

Aggressive Treatment of Early Lung Cancer Improves Survival

Aggressive surgery for early-stage NSCLC results in longer survival than more moderate surgery and an increasingly popular radiation therapy approach, according to a study by senior author James Murphy, MD.

December 6, 2017

Fate Therapeutics, UC San Diego Launch CAR NK Cancer Immunotherapy Collaboration

The collaboration will develop off-the-shelf, chimeric antigen receptor (CAR)-targeted natural killer (NK) cell cancer immunotherapies, led by Dan Kaufman, MD, PhD.

December 5, 2017

Dynavax Co-founder Takes Long View on Vaccine Development

The FDA approved a new haptatis B vaccine last month, the first Dynavax product to win FDA approval, founded by Dr. Dennis Carson.

December 5, 2017

In Multiple Myeloma, High Levels of Enzyme ADAR1 are Associated with Reduced Survival

Inhibiting ADAR1 in experimental models reduced disease recurrence in an approach known as “precision regenerative medicine”, in a Nature Communications paper with senior authors Drs. Leslie Crews and Catriona Jamieson.

December 1, 2017

State’s Stem Cell Agency Awards Nearly $8 Million for New Leukemia Therapies

UC San Diego researchers will specifically target acute myeloid leukemia, awarded to Drs. Dan Kaufman and Catriona Jamieson.

December 1, 2017

New Cancer Management Guidelines for Care of People with Kaposi Sarcoma

New NCCN guidelines for patients living with HIV who develop AIDS-related Kaposi sarcoma were developed with leadership by Panel Co-Chair Dr. Erin Reid.

November 30, 2017

Vulnerability Identified for Subtypes of Glioblastoma

Precision medicine approach may give previously tested drug a second chance, in a Cancer Cell paper led by senior author David Cheresh, PhD.

November 27, 2017

Immunotherapy Research for Head and Neck Cancers Gets Boost from V Foundation Grant

A team of researchers studying new drugs designed to break resistance to cancer immunotherapy has been awarded a V Foundation for Cancer Research translational grant of $600,000 over three years, led by Judy Varner, PhD.

November 21, 2017

Frontline Cancer: A one-size-fits-all strategy doesn't work fighting cancer

How will the funding for the the U.S. Cancer Moonshot initiative and 21st Century Cures Act be utilized in research, treatment, and prevention, questions Dr. Scott Lippman.

November 14, 2017

A New Strategy for Prevention of Liver Cancer Development

A synthetic double-stranded RNA has potential for use as an anti-liver cancer vaccine, featuring senior author Gen-Sheng Feng, PhD.

November 8, 2017

Precision medicine clinical decision support system bests oncologists at picking cancer treatment

A prominent academic medical center, a supercomputer and a California start-up came together to determine the best regimen for a patient after doctors had tried four previous times, featuring Dr. Razelle Kurzrock.

November 8, 2017

How Chronic Inflammation Tips the Balance of Immune Cells to Promote Liver Cancer

Study explains success of some types of cancer immunotherapy, provides new targets for the development of additional immunotherapies, with senior author Dr. Michael Karin.

November 1, 2017

The Forever War

A new Lancet commission report is both expansive and remarkably detailed, providing a roadmap with directions and 13 priority areas related to, among other things, early detection, immunotherapy, imaging, surgery, drug access, treatment disparities and prevention for cancer, says Dr. Scott Lippman.

October 27, 2017

What a Person's Immune System Says About Their Cancer

UC San Diego School of Medicine researchers have discovered early evidence that the genetics of a person’s immune system may help predict what that person’s cancer might look like, molecularly speaking, with lead author Hannah Carter, PhD.

October 27, 2017

Discussing Treatment Options in Thyroid Cancer

The hype of personalized medicine now is making its way into thyroid cancer, says Dr. Gregory Daniels, and a genetic-based approach to treatment may be in the future for this disease.

October 27, 2017

Recurrent Head and Neck Cancer: Continuing Encouraging Results for Pembrolizumab

Improved outcomes in subset of recurrent head and neck cancer patients with PD-LI-expressing tumors featuring the study's lead author Dr. Ezra Cohen.

October 26, 2017

UC San Diego Health Researchers Help Launch Second Pancreas Cancer “Dream Team”

New 4-year, $7-million collaborative grant will focus on preventing the deadly disease, featuring Drs. Scott Lippman and Andy Lowy.

October 26, 2017

Stand Up To Cancer Launches Four Teams on "Cancer Interception" To Detect and Treat Cancer at Earliest Stages

SU2C, the Lustgarten Foundation for Pancreatic Cancer Research, LUNGevity, and American Lung Association's LUNG FORCE Commit $16.6 Million to New Approach, featuring co-leader Dr. Scott Lippman.

October 25, 2017

How scientists hope to treat diseases by editing our RNA

Opening a new chapter in genetic medicine, scientists have devised a method of gene editing that can turn the protein-production machinery of certain cells on and off at will, featuring commentary by Dr. Catriona Jamieson.

October 24, 2017

Local Couple Donates $1M to UCSD for Development of Cancer Vaccines

A local philanthropic couple has donated $1 million to UC San Diego in support of a clinical trial aimed at developing personalized cancer vaccines that could help patients fight the disease using their own immune systems, led by Dr. Ezra Cohen.

October 20, 2017

Cutting Carbs Won't Save You From Cancer

Research shows high levels of glucose could overstimulate the production of certain proteins often found in tumors, and those proteins could cause cancer cells to grow and multiply faster, featuring Christine Zoumas, MS, RD.

October 18, 2017

Frontline Cancer: Cancer Consortium links work of five UC cancer centers

The new University of California Cancer Consortium is an alliance of UC's five cancer centers at UC Davis, UC Irvine, UCLA, UCSF and, Moores Cancer Center at UC San Diego Health, introduced by Dr. Scott Lippman.

October 18, 2017

Ultra-personal therapy: Gene tumor boards guide cancer care

Cancer patients increasingly are having their care guided by gene tumor boards, a new version of the hospital panels that traditionally decided whether surgery, radiation or chemotherapy would be best, featuring Dr. Razelle Kurzrock.

October 16, 2017

In early study, rare tumors respond to precision therapy

Treatment of rare tumors can be improved with a “precision medicine” approach of matching treatment to the molecular profile of the cancers, according to a preliminary study from UCSD researchers, first author Dr. Shumei Kato and senior author Dr. Razelle Kurzrock.

October 13, 2017

Abandoned blood cancer drug resurrected by San Diego startup

An experimental blood cancer drug shelved for safety concerns is being brought back to clinical development, and pushed by Dr. Catriona Jamieson who treated patients with the drug.

October 10, 2017

Your fitness tracker might hold the cure to cancer

A recent UCSD Study led by Sheri Hartman, PhD, looked at the impact of exercise on the brain function of breast cancer survivors, and found physical activity significantly improved cognitive processing — all via the data collected from the Fitbit on their wrist.

October 10, 2017

Powered by Chemo: Patient with Advanced Pancreatic Cancer Tackles Ironman Triathlon

On October 14, stage IV pancreatic cancer patient Mike Levine will compete in the Ironman World Championship, cheered on by his doctor, pancreatic cancer expert Dr. Paul Fanta.

October 9, 2017

Liquid Biopsy May Be New Way to Detect Liver Cancer Earlier, Easier

Researchers discover blood-based DNA test for effective, minimally invasive diagnosis of hepatocellular carcinoma, featuring Dr. Scott Lippman and Kang Zhang, MD, PhD.

October 3, 2017

New Technology Enables Shorter Radiation Treatment Time for Patients

Patients at UC San Diego Health in need of radiation therapy now have access to the next generation of radiation treatment technology, featuring Dr. Arno J. Mundt.

October 3, 2017

Breast cancer deaths continue to decline but racial disparities persist

Breast cancer death rates continue to drop nationwide, but the disease remains deadliest for African-American women, according to the latest report from the American Cancer Society, featuring Dr. Maria Elena Martinez.

October 1, 2017

DNA Mutations Shed in Blood Predicts Response to Immunotherapy in Patients with Cancer

In a first-of-its-kind study, UCSD MCC researchers report that a blood sample, or liquid biopsy, can reveal which patients will respond to checkpoint inhibitor-based immunotherapies, with authors Dr. Yulian Khagi and Dr. Razelle Kurzrock.

September 29, 2017

Ride for a Reason

Community leaders join the fight against cancer with Padres Pedal the Cause, featuring Moores Cancer Center.

September 27, 2017

Editing Genes One by One Throughout Colorectal Cancer Cell Genome Uncovers New Drug Targets

A study, published September 27 in Cancer Research, provides potential new drug targets for KRAS-driven cancers, with senior author Dr. Tariq Rana.

September 22, 2017

The Zika Virus May Someday Be Used to Treat Incurable Brain Cancer—Here’s How

Zika has caused a lot of grief and concern, but researchers think they may be able to squeeze some good out of this vicious virus, featuring Dr. Jeremy Rich.

September 20, 2017

Ironman training partners racing cancer to the finish line

Dr. Paul Fanta used molecular research to tailor a treatment for Ironman runner Mike Levine, a pancreatic cancer patient.

September 19, 2017

Keytruda Better than Standard Treatment for Advanced Head and Neck Cancer, Keynote-040 Study Shows

Keytruda (pembrolizumab) may be more beneficial than standard therapy for patients whose head and neck cancer has spread or returned after a first round of chemotherapy, featuring Dr. Ezra Cohen.

September 19, 2017

The big question: Will cancer immune therapy work for me?

Immunotherapy treatments are expensive, have side effects, work for only about one-quarter of patients, and are successful in patients with genetic mutations, says Dr. Razelle Kurzrock.

September 19, 2017

Brain Powered: Increased Physical Activity Among Breast Cancer Survivors Boosts Cognition

In the journal Cancer researchers report in a pilot study of 87 female breast cancer survivors that an increase in physical activity more than doubled the women’s post-treatment mental processing speed, with first author Sheri Hartman, PhD.

September 15, 2017

Better Calculating the Aggressiveness of Prostate Cancer

Scientists are looking for more and better ways to identify the prostate cancers that are most likely to become aggressive, featuring Dr. Christopher Kane.

September 13, 2017

Researchers Develop New Strategy to Target KRAS Mutant Cancer

In a new study, with senior author David Cheresh, PhD published this month in Cancer Discovery, researchers report that approximately half of lung and pancreatic cancers that originate with a KRAS mutation become addicted to the gene as they progress.

September 12, 2017

UC Cancer Centers Join Forces To Fight One Of California’s Top Killers

The University of California’s five cancer centers are joining forces to tackle some of the toughest challenges of a disease that kills 60,000 Californians a year and costs $14 billion in medical care and lost workplace productivity, featuring Dr. Scott Lippman.

September 7, 2017

Metastatic melanoma patients dramatically respond to combo cancer therapy

Early clinical trial results of a therapy combining a cancer-killing virus and an immune-stimulating drug for metastatic melanoma are showing dramatic results, featuring Dr. Gregory Daniels.

September 5, 2017

Zika Virus Targets and Kills Brain Cancer Stem Cells

In vitro and animal studies suggest virus that causes devastating neurological damage in developing fetuses might be new tool for improving survival rates in patients with glioblastomas, featuring Dr. Jeremy Rich.

September 1, 2017

Unmasking a Silent Killer: Ovarian Cancer

Ovarian cancer has been termed the silent killer because its presenting symptoms are often mistaken for other benign conditions, particularly the ones that affect the gastrointestinal system, or simply changes in a woman's body as she ages, featuring Dr. Ramez Eskander.

September 1, 2017

Doctors want to give their cancer patients every chance. But are they pushing off hard talks too long?

Doctors who counsel immunotherapy, experts say, are postponing conversations about palliative care and end-of-life wishes with their patients — sometimes, until it’s too late, featuring Drs. Eric Roeland and Sandip Patel.

August 24, 2017

State’s Stem Cell Agency Awards $18.2 Million Grant for B Cell Cancer Clinical Trial

UC San Diego researchers will combine an experimental drug with an approved drug in effort to boost remission rates and long-term cancer control, led by Dr. Tom Kipps, featuring Drs. Catriona Jamieson and Dennis Carson.

August 24, 2017

GPS Maps for Cancer

Pablo Tamayo, PhD and his team developed Onco-GPS, a computational method to organize individual tumor samples with shared cancer-causing alterations onto a reference map defined by their underlying cellular functions.

August 24, 2017

Setback in prostate cancer battle

Harms from PSA-based screenings may outweigh the benefits, commented Dr. Karim Kader.

August 22, 2017

Public Health Benefits When Patients with Advanced Cancer Receive Palliative Care

UCSD researchers including senior author Dr. James Murphy published findings of a study that is the first to show a relationship between palliative care and end-of-life care in the United States at a population-based level.

August 24, 2017

Writing through pain: A cancer survivor guides patients with pen and paper

A cancer survivor has launched writing programs for patients and survivors at California health care facilities including Moores Cancer Center.

August 18, 2017

GIST Tumors Linked to NF1 Mutations, Genetic Testing Needed

MCC Researchers including Dr. Jason Sicklick, in collaboration with Memorial Sloan Kettering Cancer Center and Fox Chase Cancer Center, have determined that the duodenal-jejunal flexure shows a high frequency of gastrointestinal stromal tumors (GISTs) with mutations of the NF1 gene.

August 16, 2017

Do You Need to Get a Lung Cancer Screening?

To slow the lung cancer epidemic, a new campaign from the American Lung Association highlights the lifesaving potential of lung cancer screenings, featuring Dr. Mark Onaitis.

August 15, 2017

Blood Biopsy Reveals Unique, Targetable Genetic Alterations in Patients with Rare Cancer

Using fragments of circulating tumor DNA in blood, UCSD researchers were able to identify theoretically targetable genetic alterations in 66 percent of patients with cancer of unknown primary (CUP), featuring Dr. Razelle Kurzrock.

August 13, 2017

Poison drummer Rikki Rocket to attend surfing competition

The drummer for the 1980s glam metal band Poison is scheduled to be the guest speaker Sunday at an annual surfing invitational and luau to benefit the UC San Diego Moores Cancer Center.

August 1, 2017

Female scientists share their breakthroughs at Salk Institute lecture in La Jolla

A panel of enthusiastic medical scientists spoke at the “Women Innovators in Human Health: From Bench to Beside” conference at Salk Institute, featuring Dr. Razelle Kurzrock.

July 31, 2017

Padres Pedal the Cause for Cancer Research

Padres Pedal the Cause announced the awarding of $750,000 to fund 12 collaborative research grants to three National Cancer Institute-Designated Cancer Centers in San Diego.

July 23, 2017

Cancer stem cells target of new grant to UCSD scientists

California’s stem cell agency has awarded $5.8 million to UC San Diego researchers to develop a new variation of cancer immunotherapy, led by Dr. Ezra Cohen.

July 21, 2017

Facing deadly cancer, Vista woman plans her wedding

Rather than planning her funeral, the 31-year-old Vista woman immediately started planning her wedding, treated by oncologist Dr. Kathryn Gold.

July 21, 2017

10 physicians win NCI Cancer Clinical Investigator Team Leadership Awards

MCC Investigator Dr. Eric Roeland joined 9 investigators nationwide to receive the NCI’s Cancer Clinical Investigator Team Leadership Awards.

July 21, 2017

Patient Selection in Treating HNSCCs

OncLive Insights From Dr. Ezra Cohen.

July 20, 2017

UCSD advancing glioblastoma brain cancer research

This week many Americans are hearing the world 'glioblastoma' for the first time. Dr. Jeremy Rich is leading UCSD's new treatments for this deadly form of cancer.

July 20, 2017

CIRM Approves $5.8 Million Grant for CAR-T Therapy that Targets Cancer Stem Cells

Lab-modified immune cells would be genetically boosted to improve ability to target and kill multiple cancers, with teams headed by Dr. Ezra Cohen and Dr. Tom Kipps.

July 19, 2017

Dr. Kane on Challenges Facing Genetic Testing in Prostate Cancer

Dr. Christopher Kane discusses challenges facing genetic testing for patients with prostate cancer.

July 6, 2017

Tempus to Assist University of California San Diego In Personalized Medicine Initiative

Tempus will provide Moores Cancer Center at UC San Diego Health with molecular sequencing, analysis and decision support tools to enable further research on immune checkpoint inhibitors across cancer types.

July 3, 2017

Cancer, redefined

The first approval of a tissue-agnostic treatment signals change in how oncology drugs are tested and used, featuring Dr. Razelle Kurzrock.

June 30, 2017

Local Venture Capitalist Looks To The Future Of Healthcare

Dr. Razelle Kurzrock helped to develop the algorithms for oncologists at CureMatch.

June 28, 2017

Vivace uncloaks with $40M, U.S.-China backing for cancer trials

Vivace Therapeutics has emerged from stealth with two funding rounds to the tune of $40 million as it looks to speed up work on the Hippo-YAP signaling pathway, with Kun-Liang Guan, PhD.

June 27, 2017

Harnessing Cancer’s Methylation Footprint for More Precise Diagnosis and Prognosis

The new study was published online in PNAS with Co-Senior Author Michael Karin, PhD along with collaborators at UCSD School of Medicine and colleagues in Xijing Hospital and Sun Yat-sen Cancer Center in China.

June 7, 2017

Review of Appendix Cancer Cases Finds Over Diagnosis

​Lesions of the appendix are being over diagnosed as invasive cancer, report Dr. Andy Lowy and researchers in a paper published June 7 in the journal PLOS ONE.

June 6, 2017

Cancer Cells Send Signals Boosting Survival and Drug Resistance in Other Cancer Cells

Dr. Maurizio Zanetti reports that cancer cells appear to communicate to other cancer cells, activating an internal mechanism that boosts resistance to common chemotherapies and promotes tumor survival.

June 6, 2017

Abreos Biosciences Raises $1.2 Million

Founded in 2013 at UC San Diego by Dr. Bradley Messmer and Dr. Tom Kipps, Abreos is developing point-of-care devices that monitor the levels of biologic drugs in patients for precision dose guidance.

June 4, 2017

Regional cancer task force releases initial data

Locally, communities have joined together to form a Regional Cancer Treatment Task Force to research and address cancer-related issues.

June 2, 2017

Half of all cancer deaths are avoidable. Follow these key prevention steps.

Features MCC Investigators Drs. Georgia Sadler and Samir Gupta.

May 31, 2017

In Maine, Making Cancer DNA Tests Free—And Asking Tough Questions

Researchers at UCSD published a 168-patient study on discordance in early 2016, and they hope to publish soon two more studies with about 300 patients combined.

May 31, 2017

UC San Diego hires renowned brain cancer expert Jeremy Rich

UC San Diego has recruited Dr. Jeremy Rich, a renowned Cleveland Clinic physician-scientist who grapples with the notoriously difficult problem of understanding and treating brain tumors.

May 31, 2017

Frontline Cancer: Genetic background can provide clues about possible future tumors

The research article was published in the journal Cancer Discovery earlier this year, with authors Hannah Carter, PhD and Trey Ideker, PhD.

May 30, 2017

We’re Doing Something About Colorectal Cancer Disparities

Screening for colorectal cancer is a true public health success story, featuring María Elena Martínez, PhD.

May 26, 2017

Cancer scientist tries to help others as he battles his own Stage 4 cancer

Tom Marsilje, who has Stage 4 colorectal cancer, created a website to help people make sense of clinical trials for the disease. Features Dr. Ezra Cohen.

May 25, 2017

Are basket trials the most appropriate method to capitalize on increased rates of genomic sequencing?

Dr. Razelle Kurzrock argues that it is not new and is, ultimately, a poor fit for the genomic complexity and intertumor heterogeneity uncovered by sequencing.

May 23, 2017

Future of Immunotherapy in Head and Neck Cancer May Be in Combinations

The promise of immune-based approaches was discussed during an OncLive® Peer Exchange panel, A New Era for Treatment of Advanced Head and Neck Cancer, which was moderated by Dr. Ezra Cohen.

May 22, 2017

San Diego woman: Stage zero cancer treatment deformed me

A San Diego woman is trying to bring awareness to stage zero breast cancer and what she believes was a rush to treatment, featuring Dr. Anne Wallace.

May 22, 2017

New painkiller discovered in cancer cells

This painkiller strongly inhibits acute and chronic pain in mouse models of melanoma, according to a study published Monday in Nature Neuroscience.

May 14, 2017

Blocking a tumor suppressor gene actually slows down one kind of glioblastoma

Tumor suppressor genes, as their name implies, prevent tumors. Their failure can lead to cancer. But a study led by UCSD scientists demonstrated that, in one kind of glioblastoma, inhibiting a tumor suppressor gene, called DAXX actually slows down the cancer.

May 9, 2017

UCSD Receives Significant Charitable Donation from Point Loma Rotary Club to Advance Pancreatic Research

Genetic testing for patients with prostate cancer is poised to have a major impact on both screening and treatment selection; however significant advances are still needed, according to Dr. Christopher Kane.

May 8, 2017

Expert Discusses Unleashing Promise of Genetic Testing in Prostate Cancer

The Point Loma Rotary Club visited UCSD Medical School on Friday April 21, 2017 to present the proceeds from the annual Jim Krause Memorial Charity Bicycle Ride the Point 2016 event to MCC for pancreatic cancer research.

May 4, 2017

Amid uncertain future, California's stem cell agency loses transformative leader

Story features Sanford Stem Cell Clinical Center at UC San Diego Health.

April 28, 2017

Healthy living: Personalized cancer care

This week's healthy living takes a look at a new personalized way to treat people with cancer that's happening in San Diego.

April 20, 2017

For stem cell treatments, patients, doctors, scientists must collaborate

Stem cell research begins with scientists, passes on to physicians and ends up with patients. But those roles aren’t as separate as they seem, said speakers Thursday at a special meeting held by CIRM and UCSD, featuring Dr. Catriona Jamieson.

April 19, 2017

Rock Tour “Text2Give” Supports Immunotherapy at UC San Diego Health

After participating in an immunotherapy clinical trial at Moores Cancer Center at UC San Diego Health, Rock star Rikki Rockett of Poison was declared cancer-free in July 2016.

April 19, 2017

Dr. Kane on Genetic Testing for Prostate Cancer

Dr. Christopher Kane discusses the impact of genetic testing on patients with prostate cancer.

April 12, 2017

Frontline Cancer: Center for Novel Therapeutics to open in 2019 on UCSD campus

The 135,000-square-foot facility, located next to Moores Cancer Center on the east campus of UC San Diego, will house university scientists, local research organizations and biotech companies, all focused on cancer and related chronic diseases.

April 7, 2017

‘I don’t think people will believe me’: Researchers hesitated to share immunotherapy fears

Last week a study showing that immunotherapies may lead to rapid tumor growth in a small subset of patients met with some concern among oncologists and researchers. They worried that the news could dampen enthusiasm surrounding cancer’s most promising new therapy.

April 6, 2017

In Four Related Papers, Researchers Describe New and Improved Tools for Stem Cell Research

A large team of researchers led by senior author Kelly Frazer, PhD describes a new collection of 222 systematically derived and characterized iPSC lines generated as part of the National Heart, Lung and Blood Institute’s NextGen consortium.

March 2, 2017

Freenome announces $65 million in Series A funding, led by Andreessen Horowitz

Freenome is collaborating with Dr. Sandip Patel to develop non-invasive disease screenings for cancer.

February 21, 2017

Syros’ Drug Discovery Research in Immuno-Oncology Highlighted at UCSD

Pancreatic cancer therapy collaboration between Syros and Dr. Andy Lowy, presented at UCSD MCC Symposium.

February 16, 2017

UCSD cancer symposium unites a coalition

MCC Symposium presents 2017 Duane Roth Memorial Award, to CMO and EVP of pharmaceutical giant Roche/Genentech.

February 14, 2017

Cancer Survivor and Noted Physician-Scientist Sandra Horning to Receive Roth Award

The award will be presented at the annual MCC Translational Oncology Symposium.

February 6, 2017

Halozyme Internal Press Release

Halozyme CEO Dr. Helen Torley will present at the 13th Annual Moores Cancer Center Industry/Academia Translational Oncology Symposium. ➤

October 4, 2016

UC San Diego Health Joins Precision Medicine Initiative to Tackle Pancreatic Cancer

Precision Promise brings together researchers, clinicians and drug developers, led by Dr. Andy Lowy.

May 20, 2016

Accelerated tech transfer between the drugmaker and the academic institution

The UCSD MCC and GSK collaboration is entitled "Discovery Partnerships with Academia" or DPAc. The May 2016 Technology Transfer Tactics issue interviews MCC Director of Industry Relations Ida Deichaite, PhD on page 70.

May 2, 2016

UC San Diego Sparks New Cancer-Focused Startup, Oncternal, with Exclusive Antibody License

Oncternal Therapeutics, a new cancer-focused biotechnology startup, has signed an agreement with UC San Diego to commercialize antibodies.

February 24, 2016

Emphasizing Collaboration at a Pivotal Moment in Cancer Research

MCC Director of Industry Relations Ida Deichaite, PhD's opinion article features the current cancer therapy landscape including the Cancer Moonshot and MCC symposium.

» More Press